Checklists for your notes

Since there are tons of notes, workshops and guided reading this semester, so please do check the photocopies you had before it is too late.

For your information, we had completed photocopies for CPK and CTT.

..................................................................................
Clinical Pharmacokinetics

Lectures:
1. The ideal plasma level-time curve I. By LBY
2. The ideal plasma level-time curve II. By LBY
3. Intravenous bolus dosing in a one-compartment model. By IST
4. Intravenous bolus dosing in a two-compartment model. By IST
5. Intravenous infusion I. By LBY
6. Intravenous infusion II. By LBY
7. Extravascular administration. By IST
8. Multiple intravenous dosing. By IST
9. Multiple extravascular dosing. By IST
10. Non-linear pharmacokinetics. By IST
11. Clinical pharmacokinetic applications. By IST
12. Dosing individualization. By BE
13. Pharmacokinetics in renal impairment. By BE
14. Pharmacokinetics of dialysis. By BE
15. Influence of hepatic impairment. By BE
16. Therapeutic drug monitoring services. By BE
17. TDM: Antibiotics and immunosuppressants. By LBY
18. Overview of TDM: Digoxin and anti-epileptic drugs. By SSH

Workshops:
1. Workshop 1. By IST
2. Workshop 2. By LBY
3. Workshop 3. By IST
4. Workshop 4. By IST
5. Workshop 5. By IST
6. Workshop 6. By LBY (The answer will be printed out if she posted it)
7. Workshop 7. By SSH
8. Workshop 8. By BE

Extra readings:
1. Pharmacokinetics: an overview. By IST
2. Basic principles of pharmacokinetics.
3. General approach to adjust drug dosing in hepatic failure. By BE

..............................................................................................

Current Trends in Therapeutics

Lectures:
1. HGP 1. By YBC
2. HGP 2. By YBC
3. Recent advances in DNA technology. By GSY
4. Gene therapy. By GSY
5. Proteomics. By YBC
6. New perspective in the management of cancer. By TEL
7. New perspectives in management of infectious diseases. By KP
8. Deep brain stimulation. By YPN
9. Novel drug delivery system: gene targeting. By TEL
10. Liposomes. By ADY
11. Needleless injection. By FZ

Extra reading:
1. Common Alzhemier’s treatments

...........................................................................
Cancer Chemotherapy

Lectures:
1. Cell proliferation and the cell cycle. By TEL
2. The aetiology and epidemiology of cancer. By VS
3. Diagnosis of cancer. By VS
4. Management of cancer. By KA
5. Adverse effects of cytotoxic drugs and their management. By KA
6. Cancer chemotherapy I and II. By WPS
7. Cancer chemotherapy III. By WPS
8. Palliative care. By SBS
9. Reconstituting & handling parenteral cytotoxics. By BK

Practicals:
1. The use and care of electronic infusion devices. By Eliza.
2. Report questions for cytotoxic drug reconstitution. By BK

Workshops:
1. Stability and compatibility. By SBS & SI
2. Cases for stability and compatibility.
3. Management of pain and adverse drug effects (Coming soon)

Guided readings:
Common cancers:
1. The World Health Organisation (2204) The global burden of disease: 2004 update.
2. Underwood, J.C.E. editor. General and Systemic Pathology. 3rd ed. Edinburgh:Churchill Livingstone; 2000. Lung Tumours p. 354-358, Breast Carcinoma p. 480-491, Leukaemias p.646-651
(Coming soon)

.........................................................................................
Musculoskeletal System

Lectures:
1. Peripheral nervous antimuscarinic agents. By SI
2. Neuromuscular blockers: muscle relaxants I. By AB
3. Neuromuscular blockers: muscle relaxants II. By AB
4. Fractures. By Srikumar
5. Metabolic bone disease & its management. By DC (Coming soon)
6. Common arthropathies. By SSH
7. Inflammatory arthritis. By VS
8. Antiinflammatory drugs. By SSH
9. Antiinflammatory drugs part II. By SSH
10. Systemic lupus erythematosus. By SBS
11. Progressive multiple sclerosis. By KA
12. Principles of dermatology pharmacotherapy. By BE
13. Psoriasis and psoriatic arthropathy. By LBY
14. Immunological skin conditions: Dermatitis and Eczema. By LBY
15. Immunological skin conditions II: Toxic epidermal necrolysis and Stevens-Johnson Syndrome (Coming soon)
16. Skin and soft tissue infections(Coming soon)
17. Burns (Coming soon)
18. Wound healing (Coming soon)

Workshops:
1. Workshop I
2. Workshop II

Medical Museum Sessions:
1. Functions and divisions of skeleton. By NK

Guided readings:
1. Clinician’s guide to prevention and treatment of osteoporosis.
2. SIGN Guideline 71: Management of osteoporosis. (Coming soon)
3. SIGN Guideline 48: Management of early rheumatoid arthritis. (Coming soon)
4. BAD Guideline: Psoriasis (Coming soon)

...............................................................................

Toxicology

Lectures:
1. Toxicology : Introduction. By AB
2. Atmospheric and environmental pollutants. By AB
3. Solvents, insecticides & herbicides. By AB
4. Insecticides & herbicides. By AB (Coming soon)
5. Heavy metals and chelators. (Coming soon)
6. Industrial chemicals. (Coming soon)
7. Food additives and contaminants. (Coming soon)
8. Animal toxins. (Coming soon)
9. Plant toxins. By Madhu.
10. Toxicity testing. (Coming soon)
11. Management of poisoning I. By KA.(Coming soon)
12. Management of poisoning II. By KA. (Coming soon)

.............................................................................

Clinical Pharmacy I

Lectures:
1. Philosophy of pharmaceutical care. By BE
2. Pharmaceutical care plan. By BE
3. Evidence-based medicine. By BE
4. Review of medical statistics and their application in the medical literature. By CLT
5. Critical appraisal of medical literature. By CLT
6. Introduction to pharmacoeconomics and economic evaluation. By SSH
7. Assessment of economic costs and benefits. By SSH
8. Critical appraisal of pharmacoeconomic studies. By BE
9. Drug utilization review. By SBS
10. Post marketing evaluation of medicines: pharmacoepidemiology & pharmacovigilance. By DC (Coming soon)
11. Drug information service. By Pauline

Workshops and PSDs:
1. Pharmaceutical care plan II. (Patient: YMN)
2. Pharmaceutical care plan form.
3. Compliance assessment.
4. Pharmaceutical care plan answer. (Patient: YMN)
5. Workshop on written presentation of drug enquiries. By Pauline
6. Workshop on handling drug enquiries. By Pauline
7. Role play on handling telephone drug enquiries. By Pauline
8. Drug information centre request/response form
9. Critical appraisal workshop I & II (Q&A)
10. Critical appraisal for therapy articles.
11. A pharmacist’s guide to evaluating primary medical literature.
12. Article: Effect of rosiglitazone on the frequency of diabetes
13. Waking up from the DREAM of preventing diabetes with drugs.
14. Systemic review appraisal sheet.
15. What is systemic review?
16. Interpreting meta-analysis in systematic reviews.
17. Long-term risk of CVS events with rosiglitazone: a metaanalysis.
18. Effect of rosiglitazone on the risk of myocardial infarction and death from CVS causes.
19. Pharmaceutical care plan IV. (Patient: SHA)
20. Pharmaceutical care plain IV. (Patient: RKS)

Tutorials:
1. Tutorial 1A
2. Tutorial 1B
3. Tutorial 2A (Coming soon)
4. Tutorial 2B (Coming soon)

Guided readings:
1. Opportunities and responsibilities in pharmaceutical care.
2. Pharmaceutical care: past present and future. (Coming soon)
3. ASHP statement on pharmaceutical care. (Coming soon)
4. The changing roles of pharmacists in society.
5. Pharmaceutical care plan (Coming soon)
6. Evidence based medicine: overview. (Coming soon)
7. P values and confidence intervals unpacked.
8. Forest plots: trying to see the wood and the trees.
9. Interpreting risks and ratios in therapy trials.
10. What are hazard ratios?
11. What is critical appraisal?
12. An introduction to health economics
13. Introduction into health economics
14. What is cost-effectiveness?
15. Economic evaluations (Coming soon)
16. Pharmacoeconomics (Coming soon)
17. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator (Coming soon)
18. Checklist for appraisal of a pharmacoeconomic study (Coming soon)
19. EBM Commentary I (Coming soon)
20. EBM Commentary II (Coming soon)